Don Ingber and Wyss Institute Win World Technology Awards

The World Technology Network (WTN) announced that both the Wyss Institute and Wyss Founding Director Don Ingber, M.D., Ph.D., won awards in the biotechnology category. The awards honor the world's most significant innovators in science and technology who are "creating the 21st century" -- and the Wyss Institute made an impressive showing, having won in two separate categories: one for an organization, and one for an individual.

The awards were announced during a black-tie ceremony at the Time & Life Building in New York City by the WTN in association with TIME, Fortune, CNN, Science/AAAS, and Technology Review. The theme of the event was "Nothing Will Ever Be the Same Again" -- a nod to the groundbreaking work being undertaken by the nominees, who were selected by the winners and finalists from previous awards through an intensive, global process lasting many months.

Last year, Wyss Core Faculty member James J. Collins, Ph.D., won the WTN award in the biotechnology category in recognition of his work in synthetic biology and antibiotic drug discovery.

In total, there were 50 corporate Finalists (in 10 categories) and 100 individual Finalists (in 20 categories). The nominees and winners become part of a global community of people that has been growing since 2000 who "help create our collective future and change our world," says James Clark, founder and chairman of the WTN.

In addition to being the Wyss Institute's founding director, Ingber is the Judah Folkman Professor of Vascular Biology at Harvard Medical School and in the Vascular Biology Program at Boston Children's Hospital and Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences. He also leads the Biomimetic Microsystems Platform at the Wyss Institute. Collins also holds the William F. Warren Distinguished Professorship at Boston University, where he is also a Howard Hughes Medical Institute Investigator as well as the co-director and co-founder of the Center for BioDynamics. Collins also leads the Anticipatory Medical & Biomolecular Devices Platform at the Wyss Institute.

For more information, visit:

Read 2019 times

Rate this item
(1 Vote)

Copyright © 2019 Prototype Today ®. All rights reserved.

|   Privacy Policy |   Terms & Conditions |   Contact Us |

All trademarks and registered trademarks are the property of their respective owners.

Additive Manufacturing Today